Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients)

By Ley Ludwin   Schumacher Helmut  

Current Medical Research and Opinion, Vol. 29, Iss. 1, 2013-01 ,pp. : 41-53

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the Potential Role of Alirocumab in the Management of Hypercholesterolemia in Patients with High‐Risk Cardiovascular Disease

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 8, 2015-08 ,pp. : 771-779

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular risk assessments in chronic myeloid leukemia allow identification of patients at high risk of cardiovascular events during treatment with nilotinib

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 5, 2015-05 ,pp. : E100-E101

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients

By Guthrie Robert M.   Dahlöf Björn   Jamerson Kenneth A.   Olvera Rafael   Seeber Mary   Schumacher Helmut   Oigman Wille  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1995-2008

Informa Healthcare

Access to resources Recommend Favorite

High arterial ligation and risk of anastomotic leakage in anterior resection for rectal cancer in patients with increased cardiovascular risk

By  

COLORECTAL DISEASE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1018-1027

John Wiley & Sons Inc

Access to resources Recommend Favorite